Search

NRDC signed License Agreement with Kudos Laboratories for commercialization of anti-diabetic drug Ayush-82

The agreement will now allow Kudos Laboratories India to commercialize the drug under their trade name with due acknowledgement to CCRAS, Ministry of AYUSH.

Mar 17, 2016 08:18 IST
facebook IconTwitter IconWhatsapp Icon

The National Research Development Corporation (NRDC) on 16 March 2016 signed a License Agreement with Kudos Laboratories India for commercialization of Ayush-82, an Ayurvedic formulation for prevention and management of diabetes.

The agreement will now allow Kudos Laboratories India to commercialize the drug under their trade name with due acknowledgement to Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH, Government of India.

Ayush-82 was developed by CCRAS. The CCRAS is an apex organization for research in Ayurveda under the Ministry of AYUSH.

About Kudos Laboratories India

Kudos Laboratories India, a 100 years old organization, is engaged in marketing, manufacturing and exports of the widest range of Ayurvedic / Herbal products and range of Cosmetics.

The company holds G.M.P & ISO Certifications.

Now get latest Current Affairs on mobile, Download # 1  Current Affairs App

Download our Current Affairs & GK app For exam preparation

डाउनलोड करें करेंट अफेयर्स ऐप एग्जाम की तैयारी के लिए

AndroidIOS